Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Tianjin, China, 1991-1999 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C00	Lip	53	86.8	0.0	0	0.0	0	0.0	0.0
C01-02	Tongue	187	78.1	0.0	0	0.0	0	0.0	0.0
C03-06	Oral cavity	256	78.1	0.4	1	2.0	0	3.0	1.2
C07-08	Salivary gland	141	84.4	0.0	0	0.0	0	0.0	0.0
C09	Tonsil	25	84	0.0	0	0.0	0	0.0	0.0
C11	Nasopharynx	421	69.8	0.0	0	0.0	0	0.0	0.0
C12-13	Hypopharynx	47	72.3	0.0	0	0.0	0	0.0	0.0
C15	Oesophagus	3214	47.2	0.0	0	6.0	0	6.0	0.2
C16	Stomach	7534	54.1	0.0	2	16.0	0	18.0	0.2
C17	Small intestine	181	70.7	0.0	0	0.0	0	0.0	0.0
C18	Colon	2664	66.4	0.0	0	6.0	3	9.0	0.3
C19-20	Rectum	2508	70.5	0.0	1	6.0	0	7.0	0.3
C21	Anus	46	82.6	0.0	0	0.0	0	0.0	0.0
C22	Liver	6547	20.8	0.0	1	20.0	1	22.0	0.3
C23-24	Gall bladder	1046	47	0.0	0	2.0	2	4.0	0.4
C25	Pancreas	1994	31.7	0.0	0	4.0	0	4.0	0.2
C30-31	Nose/Sinuses	170	77.6	0.0	0	0.0	3	3.0	1.8
C32	Larynx	1040	73.2	0.1	1	0.0	0	1.0	0.1
C33-34	Lung	21456	38.8	0.0	1	52.0	0	53.0	0.2
C37-38	Other thoracic organs	245	47.3	0.0	0	1.0	0	1.0	0.4
C40-41	Bone	690	46.5	0.0	0	1.0	3	4.0	0.6
C43	Melanoma skin	119	86.6	0.0	0	0.0	0	0.0	0.0
C44	Other skin	351	87.2	0.0	0	0.0	1	1.0	0.3
C45	Mesothelioma	84	76.2	0.0	0	0.0	0	0.0	0.0
C47+C49	Connective tissue	426	89.2	0.0	0	0.0	1	1.0	0.2
C50	Breast	5876	86.1	0.0	2	3.0	8	13.0	0.2
C51	Vulva	58	91.4	0.0	0	1.0	0	1.0	1.7
C53	Cervix	568	74.8	0.0	0	1.0	0	1.0	0.2
C54	Corpus uteri	722	94.6	0.0	0	0.0	0	0.0	0.0
C55	Uterus unspecified	287	50.2	0.0	0	0.0	0	0.0	0.0
C56	Ovary	1127	77	0.0	0	2.0	1	3.0	0.3
C57	Other female genital	52	73.1	0.0	0	0.0	0	0.0	0.0
C58	Placenta	62	77.4	0.0	0	0.0	0	0.0	0.0
C60	Penis	65	83.1	0.0	0	0.0	0	0.0	0.0
C61	Prostate	423	59.6	0.0	0	0.0	0	0.0	0.0
C62	Testis	73	84.9	0.0	0	0.0	0	0.0	0.0
C64	Kidney	1096	57.8	0.0	0	2.0	0	2.0	0.2
C65	Renal pelvis	146	76.7	0.0	0	0.0	0	0.0	0.0
C66	Ureter	63	87.3	0.0	0	0.0	0	0.0	0.0
C67	Urinary bladder	2023	68.1	0.0	0	2.0	1	3.0	0.1
C69	Eye	36	80.6	0.0	0	1.0	0	1.0	2.8
C70-72	Brain & nervous system	2584	51.9	0.1	3	4.0	633	640.0	24.8
C73	Thyroid	619	83.5	0.0	0	0.0	1	1.0	0.2
C74	Adrenal gland	58	70.7	0.0	0	0.0	5	5.0	8.6
C75	Other endocrine	413	73.4	0.2	1	0.0	291	292.0	70.7
C81	Hodgkin lymphoma	123	89.4	0.0	0	0.0	0	0.0	0.0
C82-85+C96	Non-Hodgkin lymphoma	1484	77.8	0.0	0	2.0	1	3.0	0.2
C90	Multiple myeloma	217	72.8	0.0	0	0.0	0	0.0	0.0
C91	Lymphoid leukaemia	309	93.9	0.0	0	0.0	0	0.0	0.0
C92-94	Myeloid leukaemia	568	95.2	0.0	0	1.0	0	1.0	0.2
C95	Leukaemia unspecified	614	69.5	0.0	0	3.0	0	3.0	0.5

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1981-1990 and 1991-1999 (Tianjin, China)
- Table6:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Tianjin, China, 1991-1999 cases followed-up until 2000)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)